SRTA
Strata Critical Medical, Inc.Company Information
- Company Name
- Strata Critical Medical, Inc.
- CIK
- CIK0001779128
- Category
- Accelerated filer
- Ticker: Exchange
- SRTA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8000
- SIC Description
- Services-Health Services
- Ticker
- SRTA
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-12-09
- Last sale
- 2026-08-10
- Shares purchased (TTM)
- 22,000
- Shares sold (TTM)
- 153,578
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 53,015,966
- Shares outstanding
- 86,213,930
- Ownership
- 61.49%
Earnings Market Reaction
- Filing date
- 2026-08-04
- Price on filing date
- —
- 1-month reaction
- 7.18%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash Equivalents At Carrying Value | 16 | 59 | 31 | - | - | - | 16 | - | - | - | - | - | ||||||
| Cash And Cash Equivalents At Carrying Value | - | 59 | 31 | 23 | 59 | 35 | 18 | 20 | 26 | 37 | 28 | 37 | ||||||
| Restricted Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 2 | 1 | 1 | 1 | ||||||
| Accounts Receivable Net Current | 43 | 40 | 40 | 38 | 28 | 22 | 20 | 24 | 28 | 24 | 21 | 21 | ||||||
| Available For Sale Securities Debt Securities Current | 6 | 0 | 30 | 53 | 55 | 85 | 109 | 116 | 116 | 114 | 138 | 136 | ||||||
| Prepaid Expense And Other Assets Current | 55 | 25 | 25 | 9 | 13 | 9 | 5 | 10 | 11 | 18 | 18 | 13 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | 0 | 0 | - | - | 11 | - | - | - | - | - | ||||||
| Assets Current | 121 | 124 | 126 | 122 | 156 | 152 | 161 | 172 | 183 | 194 | 206 | 209 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | 41 | 40 | 36 | 39 | 34 | 33 | 28 | 31 | 22 | 3 | 3 | 3 | ||||||
| Intangible Assets Net Excluding Goodwill | 60 | 46 | 48 | 50 | 14 | 14 | 8 | 14 | 14 | 20 | 21 | 42 | ||||||
| Goodwill | 107 | 89 | 88 | 85 | 44 | 42 | 16 | 43 | 40 | 40 | 40 | 39 | ||||||
| Operating Lease Right Of Use Asset | 4 | 4 | 3 | 3 | 8 | 9 | 3 | 23 | 21 | 25 | 23 | 23 | ||||||
| Other Assets Noncurrent | 0 | 24 | 24 | 9 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | 0 | 0 | - | - | 41 | - | - | - | - | - | ||||||
| Assets | 333 | 328 | 325 | 335 | 258 | 251 | 257 | 283 | 280 | 283 | 295 | 318 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 18 | 20 | 19 | 27 | 14 | 11 | 9 | 16 | 17 | 11 | 24 | 19 | ||||||
| Contract With Customer Liability Current | - | - | - | - | 9 | 8 | 7 | 7 | 9 | 8 | 7 | 7 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 4 | 3 | 1 | 4 | 4 | 4 | 5 | 5 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | 0 | 0 | - | - | 13 | - | - | - | - | - | ||||||
| Other Liabilities Current | 26 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 46 | 21 | 20 | 28 | 26 | 22 | 23 | 27 | 30 | 23 | 35 | 30 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Warrants And Rights Outstanding | 0 | 0 | 2 | 3 | 3 | 3 | 6 | 3 | 2 | 1 | 5 | 3 | ||||||
| Operating Lease Liability Noncurrent | 3 | 3 | 3 | 3 | 5 | 6 | 2 | 19 | 18 | 21 | 20 | 20 | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Other Liabilities Noncurrent | 4 | 17 | 22 | 18 | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | 0 | 0 | - | - | 4 | - | - | - | - | - | ||||||
| Liabilities | 53 | 42 | 46 | 52 | 35 | 31 | 35 | 49 | 51 | 46 | 61 | 55 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 433 | 429 | 425 | 420 | 411 | 407 | 407 | 406 | 402 | 397 | 390 | 387 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 6 | 3 | 2 | 4 | 3 | 3 | 4 | 2 | ||||||
| Retained Earnings Accumulated Deficit | -154 | -143 | -146 | -137 | -194 | -190 | -187 | -177 | -175 | -164 | -160 | -126 | ||||||
| Stockholders Equity | 279 | 286 | 279 | 283 | 223 | 220 | 222 | 233 | 229 | 237 | 234 | 263 | ||||||
| Liabilities And Stockholders Equity | 333 | 328 | 325 | 335 | 258 | 251 | 257 | 283 | 280 | 283 | 295 | 318 | ||||||
| Allowance For Doubtful Accounts Receivable | 1 | 1 | 1 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | 400 | ||||||
| Common Stock Shares Issued | 88 | 87 | 87 | 86 | 82 | 81 | 79 | 78 | 78 | 77 | 75 | 74 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialStrata Critical Medical, Inc. (SRTA) — SEC Financial Statements & Analysis
Strata Critical Medical, Inc. (SRTA) is a services-health services company, incorporated in DE. Strata Critical Medical, Inc. trades on Nasdaq as: SRTA. Strata Critical Medical, Inc. (SRTA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04. Based on that filing, Strata Critical Medical, Inc. carries a market cap of $454.35M, a P/E ratio of 11.30x, a P/B ratio of 1.63x, a P/S ratio of 1.77x, an enterprise value of $437.77M, and an EV/EBITDA multiple of -106.20x. On profitability, it posts a gross margin of 21.25%, an operating margin of -7.97%, a net margin of 15.71%, a Return on Equity (ROE) of 16.01%, a Return on Assets (ROA) of 13.62%, and a Return on Invested Capital (ROIC) of -9.43%. Per share, it reports EPS of $0.47, diluted EPS of $0.47, free cash flow per share of $-0.56, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 136.11% year-over-year, net income growth of -311.88% year-over-year, and EPS growth of -299.80% year-over-year. On the balance sheet, it maintains a current ratio of 2.64x, a quick ratio of 1.45x, working capital of $75.23M, a debt-to-equity ratio of 0.19x, a debt ratio of 0.16, an interest coverage ratio of -7.94x, free cash flow of $-48.45M (TTM), and net debt of $-16.58M. Figures sourced from SEC EDGAR.
- Market Cap
- $454.35M
- P/E TTM
- 11.30x
- EPS TTM
- $0.47
- P/B TTM
- 1.63x
- ROE TTM
- 16.01%
- ROA TTM
- 13.62%
- Debt To Equity
- 0.19x
- Free Cash Flow TTM
- $-48.45M
- Net Revenue TTM Growth 1Y
- 136.11%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Strata Critical Medical, Inc. in?
Strata Critical Medical, Inc. (SRTA) operates in the Services-Health Services industry.
What exchange does SRTA trade on?
Strata Critical Medical, Inc. (SRTA) trades on the Nasdaq.
Where is Strata Critical Medical, Inc. incorporated?
Strata Critical Medical, Inc. is incorporated in DE.
When was Strata Critical Medical, Inc. (SRTA)'s most recent SEC filing?
Strata Critical Medical, Inc. (SRTA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04.
What is SRTA's market cap?
Strata Critical Medical, Inc. (SRTA) has a market capitalization of $454.35M as of 2026-06-30.
What is SRTA's P/E ratio?
Strata Critical Medical, Inc. (SRTA)'s trailing twelve month P/E ratio is 11.30x as of 2026-06-30.
What is SRTA's EPS (earnings per share)?
Strata Critical Medical, Inc. (SRTA)'s trailing twelve month EPS is $0.47 as of 2026-06-30.
What is SRTA's ROE (return on equity)?
Strata Critical Medical, Inc. (SRTA)'s trailing twelve month Return on Equity (ROE) is 16.01% as of 2026-06-30.
What is SRTA's ROA (return on assets)?
Strata Critical Medical, Inc. (SRTA)'s trailing twelve month Return on Assets (ROA) is 13.62% as of 2026-06-30.
What is SRTA's ROIC (return on invested capital)?
Strata Critical Medical, Inc. (SRTA)'s trailing twelve month Return on Invested Capital (ROIC) is -9.43% as of 2026-06-30.
What is SRTA's EV/EBITDA?
Strata Critical Medical, Inc. (SRTA)'s trailing twelve month EV/EBITDA is -106.20x as of 2026-06-30.